A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines
Clinical trial NCT05323461 · UNKNOWN
Trial details
- NCT number
- NCT05323461
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2022-10-28
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.